MedTrace Logo

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

NCT01138215 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-07-17

No results posted yet for this study

Summary

To study about the immunogenicity, safety and efficacy of varicella-zoster virus vaccine in HIV-infected children.

Conditions

  • HIV Infections
  • Varicella-zoster Virus

Interventions

BIOLOGICAL

VZV vaccination

Dose : 0.5 ml Route : subcutaneous injection (SC)

Sponsors & Collaborators

  • Chulalongkorn University

    collaborator OTHER

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01138215 on ClinicalTrials.gov